SUVRETTA CAPITAL MANAGEMENT, LLC - 03 Dec 2024 Form 4 Insider Report for Benitec Biopharma Inc. (BNTC)

Role
Director, 10%+ Owner
Signature
Suvretta Capital Management, LLC; By: /s/Andrew Nathanson , General Counsel & Chief Compliance Officer
Issuer symbol
BNTC
Transactions as of
03 Dec 2024
Net transactions value
+$403,200
Form type
4
Filing time
05 Dec 2024, 16:36:38 UTC
Previous filing
21 Nov 2024
Next filing
26 Dec 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BNTC Common stock, par value $0.0001 per share Purchase $357,024 +37,190 +0.47% $9.60 7,957,365 03 Dec 2024 See footnotes F1, F2
transaction BNTC Common stock, par value $0.0001 per share Purchase $46,176 +4,810 +0.51% $9.60 955,124 03 Dec 2024 See footnotes F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Notes are included on Exhibit 99.1.
F2 Notes are included on Exhibit 99.1.
F3 Notes are included on Exhibit 99.1.

Remarks:

Exhibit List: Exhibit 99.1 - Explanation of Responses Exhibit 99.2 - Joint Filer Information Exhibit 99.3 - Joint Filers' Signature